This inventor holds 4 USPTO granted patents. Top assignee: Bristol-Myers Company. Active years: 1982-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982-1988
Title: Hideo Koshiyama: Innovator in Antibacterial and Antitumor Research
Introduction
Hideo Koshiyama is a notable inventor based in Musashino, Japan. He has made significant contributions to the field of microbiology, particularly in the development of antibacterial and antitumor agents. With a total of 4 patents to his name, Koshiyama's work has had a profound impact on medical research and treatment options.
Latest Patents
Koshiyama's latest patents include groundbreaking work on a microorganism for BBM 928 production. The actinomycete 'Actinomadura sp.' designated in his culture collection as Strain No. G455-101 has been deposited with the American Type Culture Collection under the Accession Number ATCC No. 31491. The taxonomic description of this microorganism is presented in detail in the specification, along with instructions for fermenting aqueous nutrient media to produce the BBM 928 antibiotic complex. This complex has demonstrated utility as an antibacterial agent against gram-positive and acid-fast bacteria and exhibits antitumor activity against experimental animal tumors. Another significant patent involves the fermentation process for BBM-928, which is a mixture of antitumor antibacterial substances produced by the fermentation of Actinomadura sp., ATCC No. 31491, under controlled conditions. The components of this mixture may be separated by silica gel thin-layer chromatography and other means.
Career Highlights
Koshiyama is currently associated with Bristol-Myers Company, where he continues to advance his research in microbiology and pharmaceuticals. His work has been instrumental in developing new therapeutic agents that address critical health challenges.
Collaborations
Throughout his career, Koshiyama has collaborated with esteemed colleagues, including Fumihide Sakai and Hiroaki Ohkuma. These partnerships have fostered innovation and enhanced the scope of his research.
Conclusion
Hideo Koshiyama's contributions to the field of microbiology and his innovative patents have positioned him as a key figure in the development of new antibacterial and antitumor agents. His ongoing work continues to inspire advancements in medical research and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile